Companies: 10,795·Total market cap: $144.5T
Beleave Inc.

Beleave Inc.

BLEVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$566
P/E Ratio
52W High$0.0001
52W Low$0.000001

Beleave Inc. (BLEVF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

blevf · pe ratio · data through Mar 31, 2019

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Beleave Inc. (BLEVF) measures how much investors pay for each dollar of the company's trailing earnings. BLEVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.08.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2019-03-31

Forward P/E
N/A
EPS (TTM)
-$0.08
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Beleave Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2001 – 2019 · Annual
PE Ratio (TTM)
5Y Avg 389.1x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 3 fiscal years · Front-end computed
Average
389.1x
3-yr mean
Median
148.6x
3-yr midpoint
Minimum
129.4x
Lowest year
Maximum
889.3x
Highest year
129.4x
Min
Q1 · 25%148.6x
Median
Q3 · 75%889.3x
Max
Historically Low

At N/A, BLEVF's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.

0th percentileHigher than 0 of 3 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Beleave Inc.
Beleave Inc.You
BLEVF
$0MN/A-$0.08
ACI Global Corporation
ACI Global Corporation
ACGJ
$0MN/A
Arch Therapeutics, Inc.
Arch Therapeutics, Inc.
ARTH
$0MN/A-$2.27
Primo Nutraceuticals Inc.
Primo Nutraceuticals Inc.
BUGVF
$0MN/A-$0.88
The Greenrose Holding Company Inc.
The Greenrose Holding Company Inc.
GNRS
$0M2.91x$1.12
Green Hygienics Holdings Inc.
Green Hygienics Holdings Inc.
GRYN
$0MN/A-$0.20
MDEChem, Inc.
MDEChem, Inc.
MDKM
$0MN/A

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 19 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2019-03-31Latest
FY2019
$-0.08
2018-03-31
FY2018
$-0.05
2017-03-31
FY2017
$-0.06
2016-03-31
FY2016
$-0.03
2015-03-31
FY2015
$-0.01
2014-03-31
FY2014
$-0.00
2013-03-31
FY2013
$-0.00
2012-03-31
FY2012
$-0.00
2011-03-31
FY2011
$-0.01
2010-03-31
FY2010
$-0.01

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Beleave Inc. (BLEVF) measures how much investors pay for each dollar of the company's trailing earnings. BLEVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.08.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.08 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BLEVF pe ratio · 6 questions

BLEVF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.08. Data sourced from Financial Modeling Prep via BLEVF's SEC 10-K and 10-Q filings.

BLEVF PE ratioWhat is BLEVF PE ratioCurrent PE ratio of BLEVFBLEVF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Beleave Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09